MedPath

French Observatory of ElectroConvulsive Therapy (ECT)

Recruiting
Conditions
Mental Disorders
Registration Number
NCT04477434
Lead Sponsor
Centre Hospitalier Henri Laborit
Brief Summary

Since the 30s, ECT has been a psychiatric treatment mainly used for drug-resistant depressive illnesses. Clinical studies have shown its therapeutic efficiency compared to standard treatments also in other psychiatric illnesses. Although efficient, ECTs also induce side effects. In France, there is currently no consensus on providing the suitest medical care. It is therefore important to review our nowadays health care models in order to maintain and improve the recommendations of the French National Agency for Accreditation and Evaluation in Health, the last of which date from 1997! Within this context, this project has the dual objective of (1) identifying ECT medical procedure in France and (2) developing research to evaluate and to improve the effectiveness of this treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Patients consecutively referred for ECT.
Exclusion Criteria
  • Not specified

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ECT efficiency on patients2018-2022
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (30)

CHU d'Angers : Site Larrey

🇫🇷

Angers, France

Clinique Mirambeau

🇫🇷

Anglet, France

CHS de Montfavet

🇫🇷

Avignon, France

CH Cote Basque

🇫🇷

Bayonne, France

Fondation bon sauveur

🇫🇷

Bégard, France

Centre de crise Esquirol

🇫🇷

Caen, France

CHU Gabriel Montpied

🇫🇷

Clermont-Ferrand, France

CH La Chartreuse

🇫🇷

Dijon, France

Clinique du domaine de Vontes

🇫🇷

Esvres-sur-Indre, France

Clinique de Pen-An-Dalar

🇫🇷

Guipavas, France

Scroll for more (20 remaining)
CHU d'Angers : Site Larrey
🇫🇷Angers, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.